Target intelligence / Profile preview

Protein phosphatase 1 regulatory inhibitor subunit 14D (PPP1R14D)

Target
PPP1R14D
Molecular classification
Regulatory subunit, Protein phosphatase inhibitor, Other (belongs to protein phosphatase 1 regulatory subunits family)
01

Overview

PPP1R14D (Protein phosphatase 1 regulatory inhibitor subunit 14D) is a regulatory protein that inhibits protein phosphatase 1 (PP1) when phosphorylated, serving as a molecular switch for the regulation of PP1 activity. By controlling the reversible phosphorylation of serine/threonine residues, PPP1R14D modulates essential signal transduction pathways. It is found with highest expression in the gastrointestinal tract and brain (hence, some aliases), and is notably upregulated in lung adenocarcinoma, where it drives cancer cell proliferation, migration, and invasion via the PKCα/BRAF/MEK/ERK signaling pathway. Dysregulation links PPP1R14D with poor cancer prognosis, identifying it as a potential biomarker and therapeutic target. PPP1R14D belongs to the family of protein phosphatase 1 regulatory subunits, and its function depends on phosphorylation events, primarily by PKC, making it an important nexus in phosphorylation-dependent cellular control[1][2][5].

Other names
Protein phosphatase 1 regulatory subunit 14DGBPIGBPI-1CPI17-likeFLJ20251MGC119014MGC119016Gastrointestinal and brain-specific PP1-inhibitory protein 1Gut and brain phosphatase inhibitor 1PKC-dependent PP1 inhibitory proteinGBPI1
02

Mechanism of action

Drugs or agents that modulate PPP1R14D likely act by modifying its phosphorylation state, thus altering its inhibitory effect on PP1 activity and downstream signaling pathways[1][2].

03

Biological functions

Inhibition of protein phosphatase 1 (PP1)Regulation of serine/threonine phosphorylationModulation of phosphatase signaling pathways (including possible effects on PP2A)Signal transductionCell cycle regulationRegulation of cell proliferation, migration, and invasion, especially in cancer biology
04

Disease associations

Cancer (notably lung adenocarcinoma, correlates with poor prognosis and advanced disease)Potentially other cancers or proliferative disorders (based on involvement in proliferation and signaling)
05

Safety considerations

Oncogenic potential: Overexpression may promote cancer cell proliferation and migrationTherapeutic modulation risk: Inhibiting or activating PPP1R14D could disrupt critical phosphorylation-based signaling in multiple tissues, including brain and gut
06

Biomarkers

PPP1R14D expression level (prognostic marker in lung adenocarcinoma, associated with tumor progression and outcome)

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory inhibitor subunit 14D (PPP1R14D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory inhibitor subunit 14D (PPP1R14D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call